Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEXAROTENE vs BEZLOTOXUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEXAROTENE vs BEZLOTOXUMAB: Safety Overview

Metric BEXAROTENE BEZLOTOXUMAB
Total FAERS Reports 759 310
Deaths Reported 134 59
Death Rate 17.7% 19.0%
Hospitalizations 177 88
Average Patient Age 66.5 yrs 68.1 yrs
% Female Patients 42.3% 68.5%
FDA Approval Date Apr 27, 2022 N/A
Manufacturer Upsher-Smith Laboratories, Inc. Merck Sharp & Dohme LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription